Recent Topics in Fibrodysplasia Ossificans Progressiva
Takenobu Katagiri (Katagiri T), Sho Tsukamoto (Tsukamoto S), Yutaka Nakachi (Nakachi Y), Mai Kuratani (Kuratani M)
Endocrinol Metab. 2018;33(3):331-338.   Published online 2018 Sep 18     DOI: https://doi.org/10.3803/EnM.2018.33.3.331
Citations to this article as recorded by Crossref logo
Alendronate disturbs femoral growth due to changes during immunolocalization of transforming growth factor-β1 and bone morphogenetic protein-2 in epiphyseal plate
Juliana Souza Vieira, Emanuelle Juliana Cunha, Juliana Feltrin de Souza, Luis Henrique Koeler Chaves, Jessica Lakes de Souza, Allan Fernando Giovanini
World Journal of Experimental Medicine.2020; 10(1): 1.     CrossRef
ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma
Katsuhiko Sekimata, Tomohiro Sato, Naoki Sakai
Chemical and Pharmaceutical Bulletin.2020; 68(3): 194.     CrossRef
Role of Signal Transduction Pathways and Transcription Factors in Cartilage and Joint Diseases
Riko Nishimura, Kenji Hata, Yoshifumi Takahata, Tomohiko Murakami, Eriko Nakamura, Maki Ohkawa, Lerdluck Ruengsinpinya
International Journal of Molecular Sciences.2020; 21(4): 1340.     CrossRef
Design of primers for direct sequencing of nine coding exons in the human ACVR1 gene
Masaru Matsuoka, Sho Tsukamoto, Yuta Orihara, Rieko Kawamura, Mai Kuratani, Nobuhiko Haga, Kenji Ikebuchi, Takenobu Katagiri
Bone.2020; 138: 115469.     CrossRef
A new diketopiperazine-like inhibitor of bone morphogenetic protein-induced osteoblastic differentiation produced by marine-derived Aspergillus sp. BFM-0085
Satoshi Ohte, Takehiro Shiokawa, Nobuhiro Koyama, Takenobu Katagiri, Chiaki Imada, Hiroshi Tomoda
The Journal of Antibiotics.2020; 73(8): 554.     CrossRef
Penicillic Acid Congener, a New Inhibitor of BMP-Induced Alkaline Phosphatase Activity in Myoblasts, Produced by the Fungus Penicillium sp. BF-0343
Nobuhiro Koyama, Yasuhiro Otoguro, Satoshi Ohte, Takenobu Katagiri, Hiroshi Tomoda
Natural Product Communications.2020; 15(9): 1934578X2094265.     CrossRef
Fibrodysplasia ossificans progressiva: current concepts from bench to bedside
Arun-Kumar Kaliya-Perumal, Tom J. Carney, Philip W. Ingham
Disease Models & Mechanisms.2020; 13(9): dmm046441.     CrossRef
Clinical Aspects and Current Therapeutic Approaches for FOP
Hiroshi Kitoh
Biomedicines.2020; 8(9): 325.     CrossRef
Propranolol and ascorbic acid in control of fibrodysplasia ossificans progressiva flare-ups due to accidental falls
Durval Batista Palhares, Deborah Ribeiro Nascimento, Marilene Garcia Palhares, Suzana Lopes Bomfim Balaniuc, Liane de Rosso Giuliani, Paula Cristhina Niz Xavier, José Mauro Goulart Brum, Fabiana Alves, Francisco Oliveira Vieira, Elaine Maria Souza-Fagunde
Intractable & Rare Diseases Research.2019; 8(1): 24.     CrossRef
Late-onset fibrodysplasia ossificans progressiva with atypical presentation: A case report
Conor M. Cunningham, J. Matthew Royeca, Samuel W. King, Hemant Pandit
Case Reports in Women's Health.2019; 23: e00134.     CrossRef
Fibrodysplasia ossificans progressiva
Gulseren Akyuz, Kardelen Gencer-Atalay, Pinar Ata
Current Opinion in Pediatrics.2019; 31(6): 716.     CrossRef
Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily
Takenobu Katagiri, Sho Tsukamoto, Yutaka Nakachi, Mai Kuratani
International Journal of Molecular Sciences.2018; 19(11): 3586.     CrossRef